Behl, T.; Kaur, I.; Sehgal, A.; Zengin, G.; Brisc, C.; Brisc, M.C.; Munteanu, M.A.; Nistor-Cseppento, D.C.; Bungau, S.
The Lipid Paradox as a Metabolic Checkpoint and Its Therapeutic Significance in Ameliorating the Associated Cardiovascular Risks in Rheumatoid Arthritis Patients. Int. J. Mol. Sci. 2020, 21, 9505.
https://doi.org/10.3390/ijms21249505
AMA Style
Behl T, Kaur I, Sehgal A, Zengin G, Brisc C, Brisc MC, Munteanu MA, Nistor-Cseppento DC, Bungau S.
The Lipid Paradox as a Metabolic Checkpoint and Its Therapeutic Significance in Ameliorating the Associated Cardiovascular Risks in Rheumatoid Arthritis Patients. International Journal of Molecular Sciences. 2020; 21(24):9505.
https://doi.org/10.3390/ijms21249505
Chicago/Turabian Style
Behl, Tapan, Ishnoor Kaur, Aayush Sehgal, Gokhan Zengin, Ciprian Brisc, Mihaela Cristina Brisc, Mihai Alexandru Munteanu, Delia Carmen Nistor-Cseppento, and Simona Bungau.
2020. "The Lipid Paradox as a Metabolic Checkpoint and Its Therapeutic Significance in Ameliorating the Associated Cardiovascular Risks in Rheumatoid Arthritis Patients" International Journal of Molecular Sciences 21, no. 24: 9505.
https://doi.org/10.3390/ijms21249505
APA Style
Behl, T., Kaur, I., Sehgal, A., Zengin, G., Brisc, C., Brisc, M. C., Munteanu, M. A., Nistor-Cseppento, D. C., & Bungau, S.
(2020). The Lipid Paradox as a Metabolic Checkpoint and Its Therapeutic Significance in Ameliorating the Associated Cardiovascular Risks in Rheumatoid Arthritis Patients. International Journal of Molecular Sciences, 21(24), 9505.
https://doi.org/10.3390/ijms21249505
